These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8760660)

  • 21. Approaches to diuretic therapy and electrolyte imbalance in congestive heart failure.
    Cody RJ; Pickworth KK
    Cardiol Clin; 1994 Feb; 12(1):37-50. PubMed ID: 8181024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The diuretic in chronic cardiac failure: a clumsy partner].
    Rocca C
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):599-606. PubMed ID: 16878721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ACE inhibition: mechanisms of cardioprotection in chronic heart failure].
    Dietz R
    Klin Wochenschr; 1991; 69 Suppl 24():24-7; discussion 27-9. PubMed ID: 1865632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ACE-inhibitors and water metabolism in heart failure].
    Guazzi MD
    Cardiologia; 1994 Dec; 39(12 Suppl 1):133-8. PubMed ID: 7634256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diuretic treatment for the sodium retention of congestive heart failure.
    Cody RJ; Kubo SH; Pickworth KK
    Arch Intern Med; 1994 Sep; 154(17):1905-14. PubMed ID: 8074594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in management for heart failure: diuretics].
    Aoyagi T; Hirata Y
    Nihon Rinsho; 1993 May; 51(5):1281-6. PubMed ID: 8331795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of heart failure treatment.
    Guyatt GH; Devereaux PJ
    Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal function during treatment of chronic renal failure with angiotensin converting enzyme inhibitors].
    Heitmann M; Rasmussen K; Nielsen JI; Møgelvang JC
    Ugeskr Laeger; 1995 Sep; 157(39):5381-4. PubMed ID: 7483050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic usage in heart failure: a continuing conundrum in 2005.
    Gupta S; Neyses L
    Eur Heart J; 2005 Apr; 26(7):644-9. PubMed ID: 15734765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS; Cruz LS; Domingues GS; Souza CA
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal adaptation to the failing heart. Avoiding a 'therapeutic misadventure'.
    Riley DJ; Weir M; Bakris GL
    Postgrad Med; 1994 Jun; 95(8):153-6. PubMed ID: 8202420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapeutic strategy in heart failure.
    Dominiak P
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S2-6. PubMed ID: 12227721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril].
    Hess B; Keusch G; Neftel K; Margelist F; Bansky G
    Schweiz Med Wochenschr; 1986 Sep; 116(39):1331-6. PubMed ID: 3022372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.